GE Healthcare Announces FDA Clearance of CARESCAPE Monitor

GE Healthcare GE today announced FDA clearance of the CARESCAPE™ Monitor B650, a flexible patient monitoring solution that supports efficient clinical decision-making. The CARESCAPE Monitor B650 improves data integration and connectivity by directly linking to the GE Healthcare CARESCAPE portfolio of monitoring products―including the latest bedside, central station and transport monitors―as well as existing GE Healthcare monitors and peripheral third-party devices.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsFDAIndustrial ConglomeratesIndustrials
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!